Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, announced that further to the Option.
Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, announced that further to the Option.
i3 Energy (I3E), an independent oil and gas company, announced the commencement of operations for the drilling of the Serenity appraisal well on UK Licence P.2358, Block 13/23c. i3 owns
Avacta Group (AVCT), a clinical stage oncology drug company, announced that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the fourth dose cohort of patients following
For the small caps the landscape this year has been brutal, governed by a liquidity crunch as investors hoarded cash in the wake of the Ukraine uncertainty, and as much
Greatland Gold (GGP), a mining development and exploration company, noted the release of an ASX announcement by Newcrest Mining Ltd earlier today providing an update on the Havieron Joint Venture.
i3 Energy (I3E), an independent oil and gas company with assets and operations in the UK and Canada, announced its monthly dividend totalling £1.6996 million / 0.1425 pence/share. Ex-Dividend 11
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Active Energy, Canadian,
While we wait for shares of Bens Creek (BEN) to find their feet, the owner of a metallurgical coal mine in North America supplying the steel industry, announced that Murat
Alkemy Capital Investments (ALK), said that VSA Capita) has initiated coverage on the company.
Oracle Power (ORCP), the international natural resources project developer, said that positive metallurgical results have been returned from the first of three samples from its 100% owned Northern Zone Gold
While investors have been looking for M&A elsewhere in the market, Tern (TERN) have announced a share offer for Pires (PIRI).
DeepVerge (DVRG), announces that Innovenn UK Limited has signed a Testing Services Framework Agreement with Abingdon Health plc for development and manufacture by Abingdon of a range of Lateral Flow